about
Update on the Management of Pediatric Acute Osteomyelitis and Septic ArthritisCompliance with anti-H1N1 vaccine among healthcare workers and general populationNon-Intensive Care Unit Acquired Pneumonia: A New Clinical Entity?The role of vaccination in preventing pneumococcal disease in adultsThe evidence on tiotropium bromide in asthma: from the rationale to the bedside.Understanding the burden of pneumococcal disease in adults.Cefditoren versus levofloxacin in patients with exacerbations of chronic bronchitis: serum inflammatory biomarkers, clinical efficacy, and microbiological eradication.Antibiotics as immunomodulant agents in COPD.Formoterol fumarate + glycopyrrolate for the treatment of chronic obstructive pulmonary disease.Choose your outcomes: From the mean to the personalized assessment of outcomes in COPD. An exploratory pragmatic survey.Role of Streptococcus pneumoniae infection in chronic obstructive pulmonary disease patients in Italy.Once daily aerosolised tobramycin in adult patients with cystic fibrosis in the management of Pseudomonas aeruginosa chronic infection.Acute exacerbations of COPD: risk factors for failure and relapse.Interstitial pneumonia with autoimmune features: an additional risk factor for ARDS?Therapeutic approach to respiratory infections in lung transplantation.Antibiotic therapy, supportive treatment and management of immunomodulation-inflammation response in community acquired pneumonia: review of recommendationsCOPD management as a model for all chronic respiratory conditions: report of the 4th Consensus Conference in Respiratory Medicine.Immunomodulatory effects of pidotimod in adults with community-acquired pneumonia undergoing standard antibiotic therapy.Quality standards for the management of bronchiectasis in Italy: a national audit.Efficacy and effectiveness of Ceftaroline Fosamil in patients with pneumonia: a systematic review and meta-analysisProteome Investigation of Rat Lungs subjected to Ex Vivo Perfusion (EVLP)Management of Acute Respiratory Failure Due to Community-Acquired Pneumonia: A Systematic ReviewManagement of severe COPD exacerbations: focus on beclomethasone dipropionate/formoterol/glycopyrronium bromideAn ounce of prevention is worth a pound of curePneumonia due to Mycoplasma, Chlamydophila and LegionellaImpact of exacerbations in the natural course of COPDStratifying Risk Factors for Multidrug-Resistant Pathogens in Hospitalized Patients Coming From the Community With PneumoniaEmerging biological therapies for treating chronic obstructive pulmonary disease: A pairwise and network meta-analysisEffects of bronchodilation on biomarkers of peripheral airway inflammation in COPDEmerging antibacterial and antiviral drugs for treating respiratory tract infections
P50
Q26743375-DB1DE520-9891-4DB7-8D4B-B818997E6362Q27002395-E3778A05-11DA-4493-B113-9350B0BCC69FQ28080078-748F0E83-5348-4084-AB3C-2A13A6AEA94FQ28396749-BA3C4BE5-35F3-4E71-BB22-8625F98D9D4CQ33644971-8A4A5875-73FE-41FE-B821-7EA5E31BC1CBQ34641396-7135ECDF-4D82-40FF-ACD5-4E973EE36A80Q36617992-61F7E1B2-D601-464E-BCBF-592F6700FCCEQ37982879-0ACB5F77-91F6-45D5-89AC-23912A5EE0F5Q39462715-7CE319B0-8C8D-421B-824E-79F73C4741ECQ39668817-870442D6-5AD3-4C20-BCAA-BEE371306DD7Q40074304-200132B0-D7EF-4505-B473-89CB4BE62261Q40338029-AE23D82D-DD48-4509-ACFE-F1E6C18DC4C3Q41072489-5BAFF8A8-3EEB-4BB3-926B-91A3564764E9Q41681887-2D094102-12A1-44E3-B887-ECF3418804FAQ42205282-BC101E11-77C0-406D-8D8C-07C7AE367585Q42370479-562B0BBF-9F31-4B69-86E8-9D2D375B5559Q47100727-B631AED4-4B15-4177-9749-101A283C284EQ50794283-1AA94F54-CC9A-455C-B397-B729ED4D48F9Q51532609-75C19A94-A784-4B10-83DE-A323D5012447Q57799639-14B6C128-10E5-4D14-A2C2-5FEBF2BE944DQ60950318-CEDD4233-0E4B-4A4B-8895-121E7845BEF2Q61818213-11C79BC3-D146-46D8-A794-1344F0D9269AQ64128571-B03166D9-6275-4D3F-BD47-BF432BC7F81BQ64128622-5966DE66-5F02-487E-8459-51A20F41DCACQ64128648-D5CE69F4-2666-4AA5-96B8-FFA30AD97584Q64128680-511E2FC6-DD4C-4724-8E90-845A0D2D9386Q64128732-40211FFF-9DC7-4057-91D1-CA0223951F0AQ88245423-166B5414-21D2-47F4-BAD8-23656F1ADEA7Q88727576-2FD09D43-53DC-4038-A0BB-53A7149B23E5Q90389913-1B58C7FC-33CF-495B-AA11-FF568405ACA6
P50
description
hulumtues
@sq
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Marco Mantero
@ast
Marco Mantero
@en
Marco Mantero
@es
Marco Mantero
@nl
Marco Mantero
@sl
type
label
Marco Mantero
@ast
Marco Mantero
@en
Marco Mantero
@es
Marco Mantero
@nl
Marco Mantero
@sl
prefLabel
Marco Mantero
@ast
Marco Mantero
@en
Marco Mantero
@es
Marco Mantero
@nl
Marco Mantero
@sl
P106
P21
P31
P496
0000-0001-7324-1217